Загрузка...
FDA-Approved Oligonucleotide Therapies in 2017
Oligonucleotides (oligos) have been under clinical development for approximately the past 30 years, beginning with antisense oligonucleotides (ASOs) and apatmers and followed about 15 years ago by siRNAs. During that lengthy period of time, numerous clinical trials have been performed and thousands...
Сохранить в:
| Опубликовано в: : | Mol Ther |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Gene & Cell Therapy
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5417833/ https://ncbi.nlm.nih.gov/pubmed/28366767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2017.03.023 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|